文献速递血液净化与透析

临床流程与动静脉内瘘穿刺及成熟的关系:多中心前瞻性队列研究

Relationships Between Clinical Processes and Arteriovenous Fistula Cannulation and Maturation: A Multicenter Prospective Cohort Study.
PubMed 文献 · Am J Kidney Dis · 2018-02-02

该多中心前瞻性队列研究纳入491例单期动静脉内瘘(AVF)患者,分析术后护理流程和并发症与穿刺尝试、穿刺成功及临床成熟的关系。结果显示90.2%患者尝试穿刺,其中97.1%最终成功,88.6%达到总体成熟;多种护理流程和并发症与成熟结局相关。

要点

  • 术后2周首次随访、常规二次随访和常规超声与穿刺尝试减少相关。
  • 有血管通路协调员的机构无辅助成熟更可能,而穿刺前非研究超声和首次穿刺失败降低无辅助成熟。
  • 穿刺成功前浸润降低总体成熟,手术至首次穿刺间隔延长降低无辅助和总体成熟。

核心结论

  • 多种护理流程和并发症与AVF成熟结局相关。

研究设计与样本

  • 7中心前瞻性队列研究,纳入491例单期AVF患者,均需维持性血液透析。

主要发现

  • 443/491(90.2%)尝试穿刺,430/443(97.1%)最终成功。
  • 263/430(61.2%)达到无辅助成熟,118/430(27.4%)达到辅助成熟,总体成熟381/430(88.6%)。
  • 外科医生政策为常规2周首次术后随访相比晚于2周,尝试穿刺OR 0.21(95%CI 0.06-0.70)。
  • 常规第二次术后随访OR 0.39(95%CI 0.15-0.97),常规临床术后超声OR 0.28(95%CI 0.14-0.55)。
  • 为促进成熟而行的操作与尝试穿刺减少相关(OR 0.51,95%CI 0.27-0.98)。

关键数值与推荐

  • 有血管通路协调员的机构无辅助成熟OR 1.91(95%CI 1.17-3.12)。
  • 穿刺前非研究超声每增加一次,无辅助成熟OR 0.42(95%CI 0.26-0.68)。
  • 初始穿刺失败每增加一次尝试,无辅助成熟OR 0.90(95%CI 0.83-0.98)。
  • 穿刺成功前浸润与总体成熟降低相关(OR 0.44,95%CI 0.22-0.89)。
  • 手术至首次穿刺每增加1个月,无辅助和总体成熟OR分别为0.81(95%CI 0.76-0.88)和0.93(95%CI 0.89-0.98)。

临床怎么用

  • 关注术后随访频率、超声使用和穿刺技术对AVF成熟的影响。
  • 考虑设置血管通路协调员以促进无辅助成熟。
  • 避免不必要的穿刺前超声和反复穿刺失败,减少浸润。

局限性

  • 外科医生管理政策仅通过研究开始时问卷评估。
  • 多数患者为上臂AVF,计划两期AVF被排除,且设定成熟时间窗。
  • 部分护理流程可能遗漏,观察性设计限制因果推断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Half of surgically created arteriovenous fistulas (AVFs) require additional intervention to effectively support hemodialysis. Postoperative care and complications may affect clinical maturation. STUDY DESIGN: Hemodialysis Fistula Maturation (HFM) Study, a 7-center prospective cohort study. SETTING & PARTICIPANTS: 491 patients with single-stage AVFs who had neither thrombosis nor AVF intervention before a 6-week postoperative ultrasonographic examination and who required maintenance hemodialysis. PREDICTORS: Postoperative care processes and complications. OUTCOMES: Attempted cannulation, successful cannulation, and unassisted and overall clinical maturation as defined by the HFM Study criteria. RESULTS: AVF cannulation was attempted in 443 of 491 (90.2%) participants and was eventually successful in 430 of these 443 (97.1%) participants. 263 of these 430 (61.2%) reached unassisted and 118 (27.4%) reached assisted AVF maturation (overall maturation, 381/430 [88.6%]). Attempted cannulation was less likely in patients of surgeons with policies for routine 2-week versus later-than-2-week first postoperative visits (OR, 0.21; 95% CI, 0.06-0.70), routine second postoperative follow-up visits (OR, 0.39; 95% CI, 0.15-0.97), and a routine clinical postoperative ultrasound (OR, 0.28; 95% CI, 0.14-0.55). Attempted cannulation was also less likely among patients undergoing procedures to assist maturation (OR, 0.51; 95% CI, 0.27-0.98). Unassisted maturation was more likely for patients treated in facilities with access coordinators (OR, 1.91; 95% CI, 1.17-3.12), but less likely after precannulation nonstudy ultrasounds (OR per ultrasound, 0.42 [95% CI, 0.26-0.68]) and initial unsuccessful cannulation attempts (OR per each additional attempt, 0.90 [95% CI, 0.83-0.98]). Overall maturation was less likely with infiltration before successful cannulation (OR, 0.44; 95% CI, 0.22-0.89). Among participants receiving maintenance hemodialysis before AVF surgery, unassisted and overall maturation were less likely with longer intervals from surgery to initial cannulation (ORs for each additional month of 0.81 [95% CI, 0.76-0.88] and 0.93 [95% CI, 0.89-0.98], respectively) and from initial to successful cannulation (ORs for each additional week of 0.87 [95% CI, 0.81-0.94] and 0.88 [95% CI, 0.83-0.94], respectively). LIMITATIONS: Surgeons' management policies were assessed only by questionnaire at study onset. Most participants received upper-arm AVFs, planned 2-stage AVFs were excluded, and maturation time windows were imposed. Some care processes may have been missed and the observational design limits causal attribution. CONCLUSIONS: Multiple processes of care and complications are associated with AVF maturation outcomes.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Allon M, Imrey PB, Cheung AK, et al. Relationships Between Clinical Processes and Arteriovenous Fistula Cannulation and Maturation: A Multicenter Prospective Cohort Study. Am J Kidney Dis. 2018. PMID: 29398178. doi:10.1053/j.ajkd.2017.10.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。